Skip to main content

Table 1 Clinical information associated with NSCLC patient cohort

From: Double-negative (CD27IgD) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations

Patient ID

Diagnosis

Age

Smoking status

Gender

Stage

Differentiation

% DN cells out of total live singlets

R160007

SqCC

70

Smoker

Female

Stage IB

Poorly differentiated

0.204

R160023

Adeno

86

Non-Smoker

Female

Stage IIB

Poorly differentiated

0.222

R160093

Sqcc

69

Smoker

Male

StageIB

Moderately differentiated

0.536

R170219

Sqcc

69

Smoker

Male

Stage IIIA

Poorly differentiated

0.643

R170133

Sqcc

62

Non-Smoker

Female

Stage IB

Poorly differentiated

0.985

R170188

Adeno

72

Smoker

Female

Stage IA

Poorly differentiated

1.088

R170018

Sqcc

74

Smoker

Female

Stage IIIA

Poorly differentiated

1.341

R170136

Sqcc

60

Smoker

Female

Stage IIIA

Moderately differentiated

1.721

R170062

Sqcc

83

Smoker

Male

Stage IB

Moderately differentiated

1.830

R150259

Sqcc

75

Smoker

Male

Stage IB

Poorly differentiated

1.943

R160116

Sqcc

73

Smoker

Male

Stage IIB

Poorly differentiated

1.969

R170016

Adeno

71

Non-Smoker

Female

Stage IB

Poorly differentiated

2.059

R160150

Adeno

71

Smoker

Female

Stage IB

Moderately differentiated

4.471

R160153

Adeno

84

Non-Smoker

Female

Stage IB

Moderately differentiated

6.269

R160250

Adeno

84

Non-Smoker

Male

Stage IIA

Moderately differentiated

8.492

  1. Smoking status was defined as smoker including the groups current and former smoker and non-smoker including the groups non-smoker and never smokers
  2. SqCC squamous cell carcinoma, Adeno adenocarcinoma